These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20303959)

  • 1. Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice.
    Guo Y; Duan W; Li Z; Huang J; Yin Y; Zhang K; Wang Q; Zhang Z; Li C
    FEBS Lett; 2010 Apr; 584(8):1615-22. PubMed ID: 20303959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
    Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
    J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1.
    Warita H; Manabe Y; Murakami T; Shiote M; Shiro Y; Hayashi T; Nagano I; Shoji M; Abe K
    Neurol Res; 2002 Sep; 24(6):577-81. PubMed ID: 12238624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
    Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
    J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the glutamate transporter variants GLT-1a and GLT-1b in the cortex and spinal cord of transgenic rats expressing hSOD1(G93A).
    Dumont AO; Hermans E; Goursaud S
    Neurochem Int; 2013 Aug; 63(2):61-8. PubMed ID: 23665075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
    J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
    Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
    Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria.
    Bilsland LG; Nirmalananthan N; Yip J; Greensmith L; Duchen MR
    J Neurochem; 2008 Dec; 107(5):1271-83. PubMed ID: 18808448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress.
    Tortarolo M; Crossthwaite AJ; Conforti L; Spencer JP; Williams RJ; Bendotti C; Rattray M
    J Neurochem; 2004 Jan; 88(2):481-93. PubMed ID: 14690536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
    Albano R; Liu X; Lobner D
    Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS.
    Yin HZ; Tang DT; Weiss JH
    Exp Neurol; 2007 Oct; 207(2):177-85. PubMed ID: 17719032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis.
    Juan L; Dawei Z; Julie AD
    Neurol Res; 2007 Mar; 29(2):204-9. PubMed ID: 17439705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study on the distribution of glycogen synthase kinase 3alpha in the central nervous system of SOD1(G93A) transgenic mice.
    Chung YH; Joo KM; Kim DJ; Kim SS; Kim KY; Lee WB; Cha CI
    Neurol Res; 2008 Nov; 30(9):926-31. PubMed ID: 18671898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.
    Benkler C; Ben-Zur T; Barhum Y; Offen D
    Glia; 2013 Mar; 61(3):312-26. PubMed ID: 23280929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells.
    Marcuzzo S; Kapetis D; Mantegazza R; Baggi F; Bonanno S; Barzago C; Cavalcante P; Kerlero de Rosbo N; Bernasconi P
    Exp Neurol; 2014 Mar; 253():91-101. PubMed ID: 24365539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
    Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
    Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.